CLOV vs TMDX · rev $1.37B vs P/E 17, rev $441.5M
Clover Health Investments Corp (CLOV) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TMDX revenue for 2024-12-31 was $441.5M. Net income was $35.5M. Revenue was up 82.7% from 2023-12-31 to 2024-12-31. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
CLOV currently screens at market cap $1.55B. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the CLOV and TMDX stock pages for the full models.
Not investment advice.